Synthesis and reactivity of Ir(I) and Ir(III) complexes with MeNH2, Me2C=NR (R = H, Me), C,N-C6H4{C(Me)=N(Me)}-2, and N,N'-RN=C(Me)CH2C(Me2)NHR (R = H, Me) ligands

Complexes [Ir(Cp*)Cl(n)(NH2Me)(3-n)]X(m) (n = 2, m = 0 (1), n = 1, m = 1, X = Cl (2a), n = 0, m = 2, X = OTf (3)) are obtained by reacting [Ir(Cp*)Cl(mu-Cl)]2 with MeNH2 (1:2 or 1:8) or with [Ag(NH2Me)2]OTf (1:4), respectively. Complex 2b (n = 1, m = 1, X = ClO 4) is obtained from 2a and NaClO4 x H2O. The reaction of 3 with MeC(O)Ph at 80 degrees C gives [Ir(Cp*){C,N-C6H4{C(Me)=N(Me)}-2}(NH2Me)]OTf (4), which in turn reacts with RNC to give [Ir(Cp*){C,N-C6H4{C(Me)=N(Me)}-2}(CNR)]OTf (R = (t)Bu (5), Xy (6)). [Ir(mu-Cl)(COD)]2 reacts with [Ag{N(R)=CMe2}2]X (1:2) to give [Ir{N(R)=CMe2}2(COD)]X (R = H, X = ClO4 (7); R = Me, X = OTf (8)). Complexes [Ir(CO)2(NH=CMe2)2]ClO4 (9) and [IrCl{N(R)=CMe2}(COD)] (R = H (10), Me (11)) are obtained from the appropriate [Ir{N(R)=CMe2}2(COD)]X and CO or Me4NCl, respectively. [Ir(Cp*)Cl(mu-Cl)]2 reacts with [Au(NH=CMe2)(PPh3)]ClO4 (1:2) to give [Ir(Cp*)(mu-Cl)(NH=CMe2)]2(ClO4)2 (12) which in turn reacts with PPh 3 or Me4NCl (1:2) to give [Ir(Cp*)Cl(NH=CMe2)(PPh3)]ClO4 (13) or [Ir(Cp*)Cl2(NH=CMe2)] (14), respectively. Complex 14 hydrolyzes in a CH2Cl2/Et2O solution to give [Ir(Cp*)Cl2(NH3)] (15). The reaction of [Ir(Cp*)Cl(mu-Cl)]2 with [Ag(NH=CMe2)2]ClO4 (1:4) gives [Ir(Cp*)(NH=CMe2)3](ClO4)2 (16a), which reacts with PPNCl (PPN = Ph3=P=N=PPh3) under different reaction conditions to give [Ir(Cp*)(NH=CMe2)3]XY (X = Cl, Y = ClO4 (16b); X = Y = Cl (16c)). Equimolar amounts of 14 and 16a react to give [Ir(Cp*)Cl(NH=CMe2)2]ClO4 (17), which in turn reacts with PPNCl to give [Ir(Cp*)Cl(H-imam)]Cl (R-imam = N,N'-N(R)=C(Me)CH2C(Me)2NHR (18a)]. Complexes [Ir(Cp*)Cl(R-imam)]ClO4 (R = H (18b), Me (19)) are obtained from 18a and AgClO4 or by refluxing 2b in acetone for 7 h, respectively. They react with AgClO4 and the appropriate neutral ligand or with [Ag(NH=CMe2)2]ClO4 to give [Ir(Cp*)(R-imam)L](ClO4)2 (R = H, L = (t)BuNC (20), XyNC (21); R = Me, L = MeCN (22)) or [Ir(Cp*)(H-imam)(NH=CMe2)](ClO4)2 (23a), respectively. The later reacts with PPNCl to give [Ir(Cp*)(H-imam)(NH=CMe2)]Cl(ClO4) (23b). The reaction of 22 with XyNC gives [Ir(Cp*)(Me-imam)(CNXy)](ClO4)2 (24). The structures of complexes 15, 16c and 18b have been solved by X-ray diffraction methods.     

Generation of Ir-Sn and Rh-Sn bonds from the oxidative addition of tin(IV) halides to [Ir(μ-Cl)(1,5-COD)]2 and [Rh(μ-Cl)(1,5-COD)]2

Facile oxidative addition of SnCl₄, MeSnCl₃, and SnBr₄ across Ir(I) and Rh(I) cyclooctadiene complexes resulted in the formation of the corresponding Ir-Sn and Rh-Sn heterobimetallic complexes. Treatment of SnCl₄ with [Ir(COD)(μ-Cl)]₂ and [Rh(COD)(μ-Cl)]₂ afforded [Ir(COD)(μ-Cl)Cl(SnCl₃)]₂ (1) and [Rh(COD)(μ-Cl)Cl(SnCl₃)]₂ (2), respectively. Reaction of the organotin halide MeSnCl₃ with [Ir(COD)(μ-Cl)]₂ led to the formation of [Ir(COD)(μ-Cl)Cl(MeSnCl₂)]₂ (3). The reaction of SnBr₄ to Ir^I and Rh^I precursors gave [Ir(COD)(μ-Br)Br(SnBr₃)]₂ (4) and [Rh(COD)(μ-Br)Br(SnBr₃)]₂ (5) respectively, which indicates halide exchange at post-oxidative addition stage. The structures of complexes 1-5 were confirmed by X-ray crystallography. A cis-addition of Sn-X bond across Ir^I/Rh^I is proposed from the analysis of the geometrical features of “X-M-Sn” triangular units in 1-5.     

Dual-reagent catalysis within Ir-Sn domain: highly selective alkylation of arenes and heteroarenes with aromatic aldehydes

Reactions of arenes and heteroarenes with aromatic aldehydes proceeded smoothly in the presence of a catalytic combination of [Ir(COD)Cl]2-SnCl4 to afford the corresponding triarylmethane derivatives (TRAMs) in high yields. This 100% TRAM selective transformation is clean and eliminates the use of acid systems.     

Synthesis and Structures of RhI and IrI Complexes Supported by N‐Heterocyclic Carbene‐Phosphinidene Adducts

N‐Heterocyclic carbene‐phosphinidene adducts of the type (IDipp)PR [R = Ph ( 5 ), SiMe₃ ( 6 ); IDipp = 1,3‐bis(2,6‐diisopropylphenyl)imidazolin‐2‐ylidene] were used as ligands for the preparation of rhodium(I) and iridium(I) complexes. Treatment of (IDipp)PPh ( 5 ) with the dimeric complexes [M(μ‐Cl)(COD)]₂ (M = Rh, Ir; COD = 1,5‐cyclcooctadiene) afforded the corresponding metal(I) complexes [M(COD)Cl{(IDipp)PPh}] [M = Rh ( 7 ) or Ir ( 8 )] in moderate to good yields. The reaction of (IDipp)PSiMe₃ ( 6 ) with [Ir(μ‐Cl)(COD)]₂ did not yield trimethylsilyl chloride elimination product, but furnished the 1:1 complex, [Ir(COD)Cl{(IDipp)PSiMe₃}] ( 9 ). Additionally, the rhodium‐COD complex 7 was converted into the corresponding rhodium‐carbonyl complex [Rh(CO)₂Cl{(IDipp)PPh}] ( 10 ) by reaction with an excess of carbon monoxide gas. All complexes were fully characterized by NMR spectroscopy, microanalyses, and single‐crystal X‐ray diffraction studies.     

Investigating pyridazine and phthalazine exchange in a series of iridium complexes in order to define their role in the catalytic transfer of magnetisation from para-hydrogen

The reaction of [Ir(IMes)(COD)Cl], [IMes = 1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene, COD = 1,5-cyclooctadiene] with pyridazine (pdz) and phthalazine (phth) results in the formation of [Ir(COD)(IMes)(pdz)]Cl and [Ir(COD)(IMes)(phth)]Cl. These two complexes are shown by nuclear magnetic resonance (NMR) studies to undergo a haptotropic shift which interchanges pairs of protons within the bound ligands. When these complexes are exposed to hydrogen, they react to form [Ir(H)₂(COD)(IMes)(pdz)]Cl and [Ir(H)₂(COD)(IMes)(phth)]Cl, respectively, which ultimately convert to [Ir(H)₂(IMes)(pdz)₃]Cl and [Ir(H)₂(IMes)(phth)₃]Cl, as the COD is hydrogenated to form cyclooctane. These two dihydride complexes are shown, by NMR, to undergo both full N-heterocycle dissociation and a haptotropic shift, the rates of which are affected by both steric interactions and free ligand pK_a values. The use of these complexes as catalysts in the transfer of polarisation from para-hydrogen to pyridazine and phthalazine via signal amplification by reversible exchange (SABRE) is explored. The possible future use of drugs which contain pyridazine and phthalazine motifs as in vivo or clinical magnetic resonance imaging probes is demonstrated; a range of NMR and phantom-based MRI measurements are reported.     

8-Oxyquinolate iridium(I) complexes and their oxidative-addition reactions

The novel sixteen-electron complex [Ir(Oq)(COD)] (Oq = 8-oxyquinolate; COD = 1,5-cyclooctadiene) adds monodentate phosphines, phosphites or activated olefins irreversibly to give pentacoordinate iridium(I) complexes of the type [Ir(Oq)(COD)L] (L = PPh₃, P(OPh)₃, maleic anhydride or tetracyano-ethylene). Reaction of [Ir(Oq)(COD)] with some diphosphines leads to substitution products of the general formula [Ir(Oq)(diphos)] (diphos = 1,2-bis(diphenylphosphino)ethane or cis-1,2-bis(diphenylphosphino)ethylene). Carbon monoxide displaces the COD group from the complexes giving either [Ir(Oq)(CO)₂] or [Ir(Oq)(CO)L], and the latter undergo oxidative addition reactions with SnCl₄, Me₃SiCl, Me₃SnCl, MeI, allylbromide, PhCOCl, MeCOCl, Cl₂, Br₂, TlCl₃ and HCl leading to novel iridium(III) complexes.     

Ir(PPh3)2(H)2(ClCH2CH2Cl)][BArF4]: a well characterised transition metal dichloroethane complex

Reaction of [Ir(PPh(3))(2)(COD)][BAr(F)(4)] with H(2) in dichloroethane solution results in [Ir(PPh(3))(2)(H)(2)(ClCH(2)CH(2)Cl)][BAr(F)(4)], which has been fully characterised by X-ray crystallography, NMR spectroscopy and ESI-MS. Its activity towards alkene hydrogenation has been compared with analogous CH(2)Cl(2) complexes.     

Stepwise and one-pot syntheses of Ir(III) complexes with imidazolium-based carbene ligands

We report the preparation, crystal structure, electrochemistry, and emission properties of Ir(Cinsertion markC:)3, where Cinsertion markC: is an N-heterocyclic carbene ligand. Two synthetic approaches are introduced for generating Ir(III) complexes bearing imidazolium-based carbene ligands whose precursors are [pypiH2][Cl] (1a) (pyridyl[1,2-a]{2-phenylimidazol}-3-ylidene chloride) and [pympiH2][Cl] (1b) (pyridyl[1,2-a-{2-(p-methoxy)phenylimidazol}-3-ylidene chloride). The first method is a stepwise reaction: treatment of [Ir(mu-Cl)(COD)]2, where COD is 1,5-cyclooctadiene, with 4 equiv. of the corresponding carbene (Cinsertion markC:) ligands in the presence of an excess amount of sodium methoxide affords Ir(III) dimers [Ir(mu-Cl)(Cinsertion markC:)2]2 (2a, Cinsertion markC: = pypi(-); 2b, Cinsertion markC: = pympi(-)). These chloro-bridged dimers 2a and 2b react with the corresponding carbene (Cinsertion markC:) ligands to form the desired homoleptic compounds Ir(Cinsertion markC:)3 (3a, Cinsertion markC: = pypi(-); 3b, Cinsertion markC: = pympi(-)). The second method, using a one-pot reaction of [Ir(mu-Cl)(COD)]2 with 6 equiv. of the corresponding carbene (Cinsertion markC:) ligands 1a and 1b in the presence of excess amounts of Ag2O, affords Ir(Cinsertion markC:)3. The two methods are convenient and reproducible procedures for the synthesis of Ir(Cinsertion markC:)3. Complexes 3a and 3b are obtained as mixtures of meridional and facial isomers, which can be separated by recrystallization or flash column chromatography.     

High throughput screening arrays of rhodium and iridium complexes as catalysts for intramolecular hydroamination using parallel factor analysis

Parallel factor analysis (PARAFAC) was used to analyze data from the high throughput screening of an array of organometallic rhodium and iridium complexes as catalysts for the intramolecular hydroamination of 2-(2-phenylethynyl)aniline to give 2-phenylindole. The progress of the hydroamination reactions was monitored using UV-visible spectroscopy. The overlapped UV-visible spectra of the mixture of starting material, product and solvent in the samples taken at different times were deconvoluted using PARAFAC. Unique PARAFAC models led to close approximations of the actual UV-visible spectra of the compounds in the mixture. The performance of the catalysts was then compared by estimating the final concentration of the starting material and product using PARAFAC loadings. A library of 63 complexes generated in situ was examined in a single experiment using this methodology. The complexes were generated from combinations of seven ligands (bis(N-methyl2-imidazolyl)methane, bis(1-pyrazolyl)methane, 1,10-phenanthroline, N,N'-bis(p-tolyl)diazabutadiene, N,N'-bis(p-tolyl)1,2-dimethyldiazabutadiene, N,N'-bis(mesityl)1,2-dimethyldiazabutadiene and bis(2,4,6-trimethylphenylimino)acenapthene) and nine metal precursors ([Ir(COD)Cl](2) (COD = 1,5-cyclooctadiene), [Ir(CO)(2)Cl](n), [Ir(COE)(2)Cl](2), [IrCp*Cl(2)](2) (Cp* = 1,2,3,4,5-pentamethylcyclopentadiene), [Rh(COD)Cl](2), [Rh(CO)(2)Cl](2), [Rh(COE)(2)Cl](2), [RhCp*Cl(2)](2) and [RhCpCl(2)](2)) (Cp = cyclopentadiene)). The proposed method can be used for the fast screening of arrays of metal complexes for identifying effective catalysts, providing information that can augment traditional methods used for the analysis of catalyzed reactions.     

Dimethylsulfoxide as a ligand for RhI and IrI complexes--isolation, structure, and reactivity towards X-H bonds (X=H, OH, OCH3)

Novel neutral and cationic Rh(I) and Ir(I) complexes that contain only DMSO molecules as dative ligands with S-, O-, and bridging S,O-binding modes were isolated and characterized. The neutral derivatives [RhCl(DMSO)(3)] (1) and [IrCl(DMSO)(3)] (2) were synthesized from the dimeric precursors [M(2)Cl(2)(coe)(4)] (M=Rh, Ir; COE=cyclooctene). The dimeric Ir(I) compound [Ir(2)Cl(2)(DMSO)(4)] (3) was obtained from 2. The first example of a square-planar complex with a bidentate S,O-bridging DMSO ligand, [(coe)(DMSO)Rh(micro-Cl)(micro-DMSO)RhCl(DMSO)] (4), was obtained by treating [Rh(2)Cl(2)(coe)(4)] with three equivalents of DMSO. The mixed DMSO-olefin complex [IrCl(cod)(DMSO)] (5, COD=cyclooctadiene) was generated from [Ir(2)Cl(2)(cod)(2)]. Substitution reactions of these neutral systems afforded the complexes [RhCl(py)(DMSO)(2)] (6), [IrCl(py)(DMSO)(2)] (7), [IrCl(iPr(3)P)(DMSO)(2)] (8), [RhCl(dmbpy)(DMSO)] (9, dmbpy=4,4'-dimethyl-2,2'-bipyridine), and [IrCl(dmbpy)(DMSO)] (10). The cationic O-bound complex [Rh(cod)(DMSO)(2)]BF(4) (11) was synthesized from [Rh(cod)(2)]BF(4). Treatment of the cationic complexes [M(coe)(2)(O=CMe(2))(2)]PF(6) (M=Rh, Ir) with DMSO gave the mixed S- and O-bound DMSO complexes [M(DMSO)(2)(DMSO)(2)]PF(6) (Rh=12; Ir=in situ characterization). Substitution of the O-bound DMSO ligands with dmbpy or pyridine resulted in the isolation of [Rh(dmbpy)(DMSO)(2)]PF(6) (13) and [Ir(py)(2)(DMSO)(2)]PF(6) (14). Oxidative addition of hydrogen to [IrCl(DMSO)(3)] (2) gave the kinetic product fac-[Ir(H)(2)Cl(DMSO)(3)] (15) which was then easily converted to the more thermodynamically stable product mer-[Ir(H)(2)Cl(DMSO)(3)] (16). Oxidative addition of water to both neutral and cationic Ir(I) DMSO complexes gave the corresponding hydrido-hydroxo addition products syn-[(DMSO)(2)HIr(micro-OH)(2)(micro-Cl)IrH(DMSO)(2)][IrCl(2)(DMSO)(2)] (17) and anti-[(DMSO)(2)(DMSO)HIr(micro-OH)(2)IrH(DMSO)(2)(DMSO)][PF(6)](2) (18). The cationic [Ir(DMSO)(2)(DMSO)(2)]PF(6) complex (formed in situ from [Ir(coe)(2)(O=CMe(2))(2)]PF(6)) also reacts with methanol to give the hydrido-alkoxo complex syn-[(DMSO)(2)HIr(micro-OCH(3))(3)IrH(DMSO)(2)]PF(6) (19). Complexes 1, 2, 4, 5, 11, 12, 14, 17, 18, and 19 were characterized by crystallography.     

[Ir(COD)(diphos)Cl配合物活化sp^3 C-H键及其促进CO、CO2插入Ir-C键反应性能的研究

本文利用[Ir(COD)(μ-Cl)]2与双膦螯合配位体之间的反应合成了三个新的配合物[Ir(COD)(diphos)]Cl(diphos=dmpe、depe、dppe),用IR、NMR、电导和元素分析测定了结构.以CH3CN为反应底物分别考察了它们活化sp^3C-H键的能力及其反应规律.在此基础上进一步研究了使CO、CO2插入生成的Ir-CH2CN键的可能性.结果表明:在温和条件下进行这一插入反应是可能的,并用光谱方法证实有相应的含羰基、羧基的金属配合物的生成.     

Iridium(III) complexes formed by O-H and/Or C-H activation of 2-(arylazo)phenols

Reaction of 2-(arylazo)phenols with [Ir(PPh(3))(3)Cl] in refluxing ethanol in the presence of a base (NEt(3)) affords complexes of three different types, viz. [Ir(PPh(3))(2)(NO-R)(H)Cl] (R = OCH(3), CH(3), H, Cl and NO(2)), [Ir(PPh(3))(2)(NO-R)(H)(2)] and [Ir(PPh(3))(2)(CNO-R)(H)]. Structures of the [Ir(PPh(3))(2)(NO-Cl)(H)Cl], [Ir(PPh(3))(2)(NO-Cl)(H)(2)] and [Ir(PPh(3))(2)(CNO-Cl)(H)] complexes have been determined by X-ray crystallography. In the [Ir(PPh(3))(2)(NO-R)(H)Cl] and [Ir(PPh(3))(2)(NO-R)(H)(2)] complexes, the 2-(arylazo)phenolate ligands are coordinated to the metal center as monoanionic bidentate N,O-donors, whereas in the [Ir(PPh(3))(2)(CNO-R)(H)] complexes, they are coordinated to iridium as dianionic tridentate C,N,O-donors. In all three products formed in ethanol, the two PPh(3) ligands are trans. Reaction of 2-(arylazo)phenols with [Ir(PPh(3))(3)Cl] in refluxing toluene in the presence of NEt(3) affords complexes of two types, viz. [Ir(PPh(3))(2)(CNO-R)(H)] and [Ir(PPh(3))(2)(CNO-R)Cl]. Structure of the [Ir(PPh(3))(2)(CNO-Cl)Cl] complex has been determined by X-ray crystallography, and the 2-(arylazo)phenolate ligand is coordinated to the metal center as a dianionic tridentate C,N,O-donor and the two PPh(3) ligands are cis. All of the iridium(III) complexes show intense MLCT transitions in the visible region. Cyclic voltammetry shows an Ir(III)-Ir(IV) oxidation on the positive side of SCE and an Ir(III)-Ir(II) reduction on the negative side for all of the products.     

Linear metal-metal-bonded tetranuclear M-Mo-Mo-M complexes (M = Ir and Rh): oxidative metal-metal bond formation in a tetrametallic system and 1,4-addition reaction of alkyl halides

Reaction of Mo2(pyphos)4 (1) with [MCl(CO)2]2 (M = Ir and Rh) afforded linear tetranuclear complexes of a formula Mo2M2(CO)2(Cl)2(pyphos)4 (2, M = Ir; 3, M = Rh). X-ray diffraction studies confirmed that two "MCl(CO)" fragments are introduced into both axial sites of the Mo2 core in 1 and coordinated by two PPh2 groups in a trans fashion, thereby forming a square-planar geometry around each M(I) metal. Treatment of 2 and 3 with an excess amount of tBuNC and XylNC induced dissociation of the carbonyl and chloride ligands to yield the corresponding dicationic complexes [Mo2M2(pyphos)4(tBuNC)4](Cl)2 (5a, M = Ir; 6a, M = Rh) and [Mo2M2(pyphos)4(XylNC)4](Cl)2 (7, M = Ir; 8, M = Rh). Their molecular structures were characterized by spectroscopic data as well as X-ray diffraction studies of BPh4 derivatives [Mo2M2(pyphos)4(tBuNC)4](BPh4)2 (5b, M = Ir; 6c, M = Rh), which confirmed that there is no direct sigma-bonding interaction between the M(I) atom and the Mo2 core. The M(I) atom in 5 and 6 can be oxidized by either 2 equiv of [Cp2Fe][PF6] or an equimolar amount of I2 to afford Mo(II)2M(II)2 complexes, [Mo2M2(X)2(tBuNC)4(pyphos)4]2+ in which two Mo-M(II) single bonds are formed and the bond order of the Mo-Mo moiety has been decreased to three. The Ir(I) complex 5a reacted not only with methyl iodide but also with dichloromethane to afford the 1,4-oxidative addition products [Mo2Ir2(CH3)(I)(tBuNC)4(pyphos)4](Cl)2 (13) and [Mo2Ir2(CH2Cl)(Cl)(tBuNC)4(pyphos)4](Cl)2 (15), respectively, although the corresponding reactions using the Rh(I) analogue 6 did not proceed. Kinetic analysis of the reaction with CH3I suggested that the 1,4-oxidative addition to the Ir(I) complex occurs in an SN2 reaction mechanism.     

Pyrazolyl-bridged iridium dimers. 18.(1) influence of metal-metal bonding on the geometry of diiridium(II) adducts and hydrido-diiridium complexes formed from the diiridium(I) prototype [Ir(mu-pz)(PPh(3))(CO)](2) (pzH = Pyrazole) by dihydrogen addition or protonation

Slow uptake of molecular dihydrogen by the diiridium(I) prototype [Ir(mu-pz)(PPh(3))(CO)](2) (1: pzH = pyrazole) is accompanied by formation of a 1,2-dihydrido-diiridium(II) adduct [IrH(mu-pz)(PPh(3))(CO)](2) (2), for which an X-ray crystal structure determination reveals that (unlike in 1) the PPh(3) ligands are axial, with the hydrides occupying trans coequatorial positions across the Ir-Ir bond (2.672 A). Reaction with CCl(4) effects hydride replacement in 2, affording the monohydride Ir(2)H(Cl)(mu-pz)(2)(PPh(3))(2)(CO)(2) (3) in which Ir-Ir = 2.683 A. At one metal center, H is equatorial and PPh(3) is axial, while at the other, Cl is axial as is found in the symmetrically substituted product [Ir(mu-pz)(PPh(3))(CO)Cl](2) (4) (Ir-Ir = 2.754 A) that is formed by action of CCl(4) on 1. Treatment of 1 with I(2) yields the diiodo analogue 5 of 4, which reacts with LiAlH(4) to afford the isomorph Ir(2)H(I)(mu-pz)(2)(PPh(3))(2)(CO)(2) (6) of 3 (Ir-Ir = 2.684 A). Protonation (using HBF(4)) of 1 results in formation of the binuclear cation Ir(2)H(mu-pz)(2)(PPh(3))(2)(CO)(2)(+) (7: BF(4)(-) salt), which shows definitive evidence (from NMR) for a terminally bound hydride in solution (CH(2)Cl(2) or THF), but 7 crystallizes as an axially symmetric unit in which Ir-Ir = 2.834 A. Reaction of 7 with water or wet methanol leads to isolation of the cationic diiridium(III) products [Ir(2)H(2)(mu-OX)(mu-pz)(2)(PPh(3))(2)(CO)(2)]BF(4) (8, X = H; 9, X = Me).     

Protonation reactions of dinuclear pyrazolato iridium(I) complexes

The complex [[Ir(mu-Pz)(CNBu(t))(2)](2)] (1) undergoes double protonation reactions with HCl and with HO(2)CCF(3) to give the neutral dihydride complexes [[Ir(mu-Pz)(H)(X)(CNBu(t))(2)](2)] (X = Cl, eta(1)-O(2)CCF(3)), in which the hydride ligands were located trans to the X groups and in the boat of the complexes, both in the solid state and in solution. The complex [[Ir(mu-Pz)(H)(Cl)(CNBu(t))(2)](2)] evolves in solution to the cationic complex [[Ir(mu-Pz)(H)(CNBu(t))(2)](2)(mu-Cl)]Cl. Removal of the anionic chloride by reaction with methyltriflate allows the isolation of the triflate salt [[Ir(mu-Pz)(H)(CNBu(t))(2)](2)(mu-Cl)]OTf. This complex undergoes a metathesis reaction of hydride by chloride in CDCl(3) under exposure to the direct sunlight to give the complex [[Ir(mu-Pz)(Cl)(CNBu(t))(2)](2)(mu-Cl)]OTf. Protonation of both metal centers in [[Ir(mu-Pz)(CO)(2)](2)] with HCl occurs at low temperature, but eventually the mononuclear compound [IrCl(HPz)(CO)(2)] is isolated. The related complex [[Ir(mu-Pz)(CO)(P[OPh](3))](2)] reacts with HCl and with HO(2)CCF(3) to give the neutral Ir(III)/Ir(III) complexes [[Ir(mu-Pz)(H)(X)(CO)(P[OPh](3))](2)], respectively. Both reactions were found to take place stepwise, allowing the isolation of the intermediate monohydrides. They are of different natures, i.e., the metal-metal-bonded Ir(II)/Ir(II) compound [(P[OPh](3))(CO)(Cl)Ir(mu-Pz)(2)Ir(H)(CO)(P[OPh](3))] and the mixed-valence Ir(I)/Ir(III) complex [(P[OPh](3))(CO)Ir(mu-Pz)(2)Ir(H)(eta(1)-O(2)CCF(3))(CO)(P[OPh](3))].     

π-Olefin—iridium -komplexe : III. Über (η4-cyclodien)(η5-cyclodienyl)iridium-verbindungen,einen neuartigen hydridoiridium-komplex und das (η4-cyclooctadien)(η6-cyclooctatrien)iridium-kation

The complexes [Ir(COD)(η⁵-C₇H₉)] and [Ir(COD)(η⁵-C₈H₁₁)] are obtained by the isoprophyl Grignard synthesis of [Ir(COD)Cl]₂ (COD = η⁴-1,5-cyclooctadiene) in the presence of cycloheptatriene, and cyclooctatriene, respectively. The later reaction yields [IrH(COD)(δ⁴-1,3,6-C₈H₁₀)] as a by-product which, in contrast to other [IrH(η⁴-cyclodiene)₂] complexes, does not show H-addition-elimination equilibria. Reduction of [Ir(1,3-C₇H₁₀)₂Cl] with C₂H₅OH/Na₂CO₃ yields [Ir(η⁴-1,3-C₇H₁₀)](η⁵-C₇H₉)] which was characterized by X-ray analysis. [Ir(COD)Cl]₂ reacts with Na₂C₈H₈, and after hydrolysis unstable [Ir(COD)(η⁵-C₈H₉)] is formed which by protonation with HPF₆ is converted into the [Ir(COD)(η⁶-1,3,5-C₈H₁₀)]⁺ cation. All these compounds are fluxional in solution.     

Preparation and structural characterization of ionic five-coordinate palladium(II) and platinum(II) complexes of the ligand tris[2-(diphenylphosphino)ethyl]phosphine. Insertion of SnCl(2) into M-Cl bonds (M = Pd,Pt) and hydroformylation activity of the Pt-SnCl(3) systems

The five-coordinate palladium(II) and platinum(II) complexes [M(PP(3))Cl]Cl [M = Pd (1), Pt (2)] (PP(3) = tris[2-(diphenylphosphino)ethyl]phosphine) were prepared by interaction of aqueous solutions of MCl(4)(2-) salts with PP(3) in CHCl(3). Complexes 1 and 2 undergo facile chloro substitution reactions with KCN in 1:1 and 1:2 ratios to afford complexes [M(PP(3))(CN)]Cl [M = Pt (3)] and [M(PP(3))(CN)](CN) [M = Pd (4), Pt (5)] possessing M-C bonds, both in solution and in the solid state. The reaction of 1 and 2 with SnCl(2) in CDCl(3) occurs with insertion of SnCl(2) into M-Cl bonds leading to the formation of [M(PP(3))(SnCl(3))](SnCl(3)) [M = Pd (6), M = Pt (7)]. The isolation as solids of complexes 6 and 7 by addition of SnCl(2) to the precursors requires the presence of PPh(3) which activates the cleavage of M-Cl bonds, favors the SnCl(2) insertion, and does not coordinate to M in any observable extent. Solutions of 6 in CDCl(3) undergo tin dichloride elimination in higher proportion than solutions of 7. The reaction of complexes 1 and 2 with SnPh(2)Cl(2) leads to [M(PP(3))Cl](2)[SnPh(2)Cl(4)] [M = Pd (8)]. Complexes 2, 5, 7, and 8 were shown by X-ray diffraction to contain distorted trigonal bipyramidal monocations [M(PP(3))X](+) [M = Pt, X = Cl(-) (2), X = CN(-) (5), X = SnCl(3)(-) (7); M = Pd, X = Cl(-) (8)], the central P atom of PP(3) being trans to X in axial position and the terminal P donors in the equatorial plane of the bipyramids. The "preformed" catalyst 7 showed a relatively high aldehyde selectivity compared to most of the platinum catalysts.     

Pentacoordinated iridium(I) complexes incorporating azopyridine chelation. Synthesis,structure and bonding

The reaction of [Ir(COD)Cl]₂ with 2-(arylazo)pyridine (L) in dichloromethane solution has afforded the nonelectrolytic pentacoordinated species of type Ir(L)(COD)(Cl) from which the corresponding bromides and iodides have been synthesised by metathesis (COD=1,5-cyclooctadiene). L ligands used are: 2-(phenylazo)pyridine (L¹); 2-(m-tolylazo)pyridine (L²) and 2-(p-chlorophenylazo)pyridine (L³). The X-ray structures of Ir(L²)(COD)(Cl)·0.5 CH₂Cl₂ and Ir(L³)(COD)(I) have been determined revealing square-pyramidal geometry. The relatively short IrN(azo) lengths (∼2.00 Å) and the relatively long NN bond distance (∼1.30 Å) are consistent with significant dππ* (azo) back-bonding. The HOMO (50% Ir and 15% azo character) and LUMO (50% azo and 30% Ir character) are primarily localised in the IrL fragment and the absorption bands near 600 nm is assigned tentatively to the HOMO→LUMO transition. The stability of the pentacoordinated structures and the inertness to oxidative addition of the present complexes in contrast to the behaviour of corresponding 2,2′-bipyridine species (tetracoordinated, reactive) is rationalised in terms of π-acidity order L≫bpy.     

Platinum and palladium complexes of thiosemicarbazones derived of 2-acetylthiophene: Synthesis and spectral studies

The reaction of 2-acetylthiophene thiosemicarbazone (2-HATT) and 2-acetylthiophene 4-phenylthiosemicarbazone (2-HAT-4-FT) with Pd(COD)Cl(2) (COD = 1,5-cyclooctadiene) and trans-Pt(2)PEt(3)Cl(4) yielded four new metal complexes: [Pd(2-HATT)Cl(2)] (1), [Pd(2-ATT)(2)] (2), [Pd(2-AT-4-FT)Cl] (3) and [Pt(2-ATT)(PEt(3))Cl] (4). Apart from compound 3 all the others were characterised by (1)H and (13)C{(1)H} NMR, infrared spectroscopy, and elemental analysis. Multinuclear NMR experiments of (31)P{(1)H} and (195)Pt{(1)H} of complex 4 have revealed that the ligand 2-HATT behaves as a bidentate chelating agent towards Pd(COD)Cl(2) and trans-Pt(2)PEt(3)Cl(4) whereas ligand 2-HAT-4-FT forms a tridentate chelating complex with Pd(COD)Cl(2).     

Stepwise formation of iridium(III) complexes with monocyclometalating and dicyclometalating phosphorus chelates

With the motivation of assembling cyclometalated complexes without nitrogen-containing heterocycle, we report here the design and systematic synthesis of a class of Ir(III) metal complexes functionalized with facially coordinated phosphite (or phosphonite) dicyclometalate tripod, together with a variety of phosphine, chelating diphosphine, or even monocyclometalate phosphite ancillaries. Thus, treatment of [IrCl(3)(tht)(3)] with stoichiometric amount of triphenylphosphite (or diphenyl phenylphosphonite), two equiv of PPh(3), and in presence of NaOAc as cyclometalation promoter, gives formation of respective tripodal dicyclometalating complexes [Ir(tpit)(PPh(3))(2)Cl] (2a), [Ir(dppit)(PPh(3))(2)Cl] (2b), and [Ir(dppit)(PMe(2)Ph)(2)Cl] (2c) in high yields, where tpitH(2) = triphenylphosphite and dppitH(2) = diphenyl phenylphosphonite. The reaction sequence that afforded these complexes is established. Of particular interest is isolation of an intermediate [Ir(tpitH)(PPh(3))(2)Cl(2)] (1a) with monocyclometalated phosphite, together with the formation of [Ir(tpit)(tpitH)(PPh(3))] (3a) with all tripodal, bidentate, and monodentate phosphorus donors coexisting on the coordination sphere, upon treatment of 2a with a second equiv of triphenylphosphite. Spectroscopic studies were performed to explore the photophysical properties. For all titled Ir(III) complexes, virtually no emission can be observed in either solution at room temperature or 77 K CH(2)Cl(2) matrix. Time-dependent DFT calculation indicates that the lowest energy triplet manifold involves substantial amount of metal centered (3)MC dd contribution. Due to its repulsive potential energy surface (PES) that touches the PES of ground state, the (3)MC dd state executes predominant nonradiative deactivation process.